Evidence of Whooping-cough-vaccine Efficacy from the 1978 Whooping-cough Epidemic in Hertfordshire
Overview
Authors
Affiliations
The question of the efficacy of whooping-cough immunisation was central to the controversy that started in 1974. Definitive answers were not possible at the time because of the very low levels of whooping-cough in the preceding years and the absence of up-to-date information. The widespread abandonment of whooping-cough immunisation and the subsequent epidemic of whooping-cough have provided a natural epidemiological experiment. Figures from Hertfordshire in 1978 show that for children aged 4 years and under whooping-cough immunisation conferred 92% protection.
Characterization of co-purified acellular pertussis vaccines.
Xu Y, Tan Y, Asokanathan C, Zhang S, Xing D, Wang J Hum Vaccin Immunother. 2015; 11(2):421-7.
PMID: 25610957 PMC: 4514368. DOI: 10.4161/21645515.2014.988549.
Ross P, Sutton C, Higgins S, Allen A, Walsh K, Misiak A PLoS Pathog. 2013; 9(4):e1003264.
PMID: 23592988 PMC: 3617212. DOI: 10.1371/journal.ppat.1003264.
Support for preventive public health programs.
Butler-Jones D Can Fam Physician. 2011; 33:1051-2.
PMID: 21263917 PMC: 2218457.
Mills K, Ryan M, Ryan E, Mahon B Infect Immun. 1998; 66(2):594-602.
PMID: 9453614 PMC: 107945. DOI: 10.1128/IAI.66.2.594-602.1998.
Toward safer and more efficient pertussis vaccines.
Wegmann A, GLUCK R Eur J Pediatr. 1996; 155(2):71-3.
PMID: 8775215 DOI: 10.1007/BF02075752.